Outcomes of early inhaled nitric oxide use in premature African American neonates

1.Subhedar NV, Shaw NJ. Modifications in oxygenation and pulmonary haemodynamics in preterm infants handled with inhaled nitric oxide. Arch Dis Baby Fetal Neonatal Ed. 1997;77:F191–97.2.Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, et al. Inhaled nitric oxide in untimely neonates with extreme hypoxaemic respiratory failure:a randomised managed trial. Lancet. 1999;354:1061–5.three.Srisuparp P, Heitschmidt M, Schreiber MD. Inhaled nitric oxide remedy in untimely infants with delicate to reasonable respiratory misery syndrome. J Med Assoc Thai. 2002;85:S469–78.four.Schreiber MD, Gin-Mestan Ok, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in untimely infants with the respiratory misery syndrome. N Engl J Med. 2003;349:2099–107.5.Subject D, Elbourne D, Truesdale A, Grieve R, Hardy P, Fenton AC, et al. Neonatal air flow with inhaled nitric oxide versus ventilatory assist with out inhaled nitric oxide for preterm infants with extreme respiratory failure: the INNOVO multicentre randomized managed trial. Pediatrics. 2005;115:926–36.6.Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, et al. Inhaled nitric oxide for untimely infants with extreme respiratory failure. N Engl J Med. 2005;353:13–22.7.Hascoet JM, Fresson J, Claris O, Hamon I, Lombet J, Liska A, et al. The protection and efficacy of nitric oxide remedy in untimely infants. J Pediatr. 2005;146:318–23.eight.Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF. Inhaled nitric oxide in very preterm infants with extreme respiratory misery syndrome. Acta Paediatr. 2006;95:1116–23.9.Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, et al. Early inhaled nitric oxide remedy in untimely newborns with respiratory failure. N Engl J Med. 2006;355:354–64.10.Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Inhaled nitric oxide in preterm infants present process mechanical air flow. N Engl J Med. 2006;355:343–53.11.Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Subject D, et al. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in untimely infants(EUNO): a randomised managed trial. Lancet. 2010;376:346–54.12.Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2010;CD000509.13.Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, et al. Inhaled nitric oxide in preterm infants: a scientific evaluate. Pediatrics. 2011;127:e414–22.14.Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Subject D, et al. Inhaled nitric oxide in preterm infants: an individual-patient information meta-analysis of randomized trials. Pediatrics. 2011;128:729–39.15.Kumar P. Committee on fetus and new child, American Academy of pediatrics. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133:164–70.16.Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D, et al. NIH consensus improvement convention assertion: inhaled nitric-oxide remedy for untimely infants. Pediatrics. 2011;127:363–9.17.Carey WA, Weaver AL, Mara KC, Clark RH. Inhaled nitric oxide in extraordinarily untimely neonates with respiratory misery syndrome. Pediatrics. 2018;141:e20173108.18.Askie LM, Davies LC, Schreiber MD, Hibbs AM, Ballard PL, Ballard RA. Race results of inhaled nitric oxide in preterm infants: a person participant information meta-analysis. J Pediatr. 2018;193:34–39.19.Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, et al. Impact of inhaled nitric oxide on survival with out bronchopulmonary dysplasia in preterm infants: a randomized medical trial. JAMA Pediatr. 2017;171:1081–9.20.Ellsworth MA, Harris MN, Carey WA, Spitzer AR, Clark RH. Off-label use of inhaled nitric oxide after launch of NIH consensus assertion. Pediatrics. 2015;135:643–eight.21.D’Agostino RB Jr. Propensity rating strategies for bias discount within the comparability of a remedy to a non-randomized management group. Stat Med. 1998;17:2265–81.22.Austin PC. Stability diagnostics for evaluating the distribution of baseline covariates between remedy teams in propensity-score matched samples. Stat Med. 2009;28:3083–107.23.Therneau TM, Grambsch PM. Modeling survival information: extending the Cox mannequin. New York, NY: Spriger-Verlag; 2000.24.Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: remaining information for 2016. Natl Important Stat Rep. 2018;67:1–55.25.Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: remaining information for 2015. Natl Important Stat Rep. 2018;66:1–75.26.Revenue J, Gould JB, Bennett M, Goldsetin BA, Draper D, Phibbs CS, et al. Racial/ethnic disparity in NICU high quality of care. Pediatrics. 2017;172:17–23.27.Howell EA, Janevic T, Hebert PL, Egorova NN, Balbierz A, Zeitlin J. Variations in morbidity and mortality charges in black, white and Hispanic very preterm infants amongst New York hospitals. JAMA Pediatr. 2018;172:269–77.28.Hornik CP, Sherwood AL, Cotten CM, Laughon MM, Clark RH, Smith PB. Day by day mortality of infants born at lower than 30weeks’ gestation. Early Hum Dev. 2016;99:27–30.29.Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, Partridge JC, Rogers EE, Keller RL. Persistent pulmonary hypertension of the new child in late preterm and time period infants in California. Pediatrics. 2017;139:e20161165.30.Wallace ME, Mendola P, Kim SS, Epps N, Chen Z, Smarr M, et al. Racial/ethnic variations in preterm perinatal outcomes. Am J Obstet Gynecol. 2017;216:306.e1–12.31.Finer NN, Evans N. Inhaled nitric oxide for the preterm toddler: proof versus observe. Pediatrics. 2015;135:754–6.

LEAVE A REPLY

Please enter your comment!
Please enter your name here